These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8569212

  • 1. Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings.
    Darpö B, Vallin H, Almgren O, Bergstrand R, Insulander P, Edvardsson N.
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):530-40. PubMed ID: 8569212
    [Abstract] [Full Text] [Related]

  • 2. Tolerance and effects of almokalant, a new selective Ik blocking agent, on ventricular repolarization and on sino-atrial and atrioventricular nodal function in the heart: a study in healthy, male volunteers utilizing transesophageal atrial stimulation.
    Darpö B, Almgren O, Bergstrand R, Bäärnhielm C, Gottfridsson C, Sandstedt B, Edvardsson N.
    J Cardiovasc Pharmacol; 1995 May; 25(5):681-90. PubMed ID: 7630145
    [Abstract] [Full Text] [Related]

  • 3. Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.
    Darpö B, Almgren O, Bergstrand R, Franzén S, Edvardsson N.
    Cardiovasc Drugs Ther; 1996 Nov; 10(5):539-47. PubMed ID: 8950068
    [Abstract] [Full Text] [Related]

  • 4. Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pig.
    Wiesfeld AC, De Langen CD, Crijns HJ, Bel KJ, Hillege HL, Wesseling H, Lie KI.
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):594-600. PubMed ID: 8847879
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pig.
    Tuininga YS, De Langen CD, Crijns HJ, Wiesfeld AC, Mook PH, Bel KJ, Lie KI.
    Pacing Clin Electrophysiol; 1996 May; 19(5):802-10. PubMed ID: 8734747
    [Abstract] [Full Text] [Related]

  • 6. Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle.
    Yuan S, Wohlfart B, Rasmussen HS, Olsson S, Blomström-Lundqvist C.
    Eur Heart J; 1994 Apr; 15(4):514-22. PubMed ID: 8070479
    [Abstract] [Full Text] [Related]

  • 7. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris.
    Sedgwick ML, Rasmussen HS, Cobbe SM.
    Am J Cardiol; 1992 Dec 01; 70(18):1432-7. PubMed ID: 1442614
    [Abstract] [Full Text] [Related]

  • 8. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L, Abrahamsson C, Andersson B, Duker G, Schiller-Linhardt G.
    Cardiovasc Res; 1993 Dec 01; 27(12):2186-93. PubMed ID: 8313427
    [Abstract] [Full Text] [Related]

  • 9. Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias.
    Wiesfeld AC, Crijns HJ, Tobé TJ, Almgren O, Bergstrand RH, Aberg J, Haaksma J, Lie KI.
    Am J Cardiol; 1992 Oct 15; 70(11):990-6. PubMed ID: 1384304
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dog.
    Duker G, Almgren O, Carlsson L.
    J Cardiovasc Pharmacol; 1992 Sep 15; 20(3):458-65. PubMed ID: 1279293
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lidocaine and nisoldipine attenuate almokalant-induced dispersion of repolarization and early afterdepolarizations in vitro.
    Abrahamsson C, Carlsson L, Duker G.
    J Cardiovasc Electrophysiol; 1996 Nov 15; 7(11):1074-81. PubMed ID: 8930739
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE.
    Cardiovasc Drugs Ther; 2012 Dec 15; 26(6):489-500. PubMed ID: 22918600
    [Abstract] [Full Text] [Related]

  • 16. QRS aberration during atrial fibrillation at rest and during exercise. Effect of a selective potassium channel blocking agent.
    Houltz B, Darpö B, Crijns HJ, Swedberg K, Blomström P, Jensen SM, Svernhage E, Edvardsson N.
    J Electrocardiol; 2002 Jul 15; 35(3):201-12. PubMed ID: 12122610
    [Abstract] [Full Text] [Related]

  • 17. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control.
    Verduyn SC, Vos MA, van der Zande J, Kulcsàr A, Wellens HJ.
    J Am Coll Cardiol; 1997 Nov 15; 30(6):1575-84. PubMed ID: 9362418
    [Abstract] [Full Text] [Related]

  • 18. Prevention of class III-induced proarrhythmias by flecainide in an animal model of the acquired long QT syndrome.
    Hallman K, Carlsson L.
    Pharmacol Toxicol; 1995 Oct 15; 77(4):250-4. PubMed ID: 8577635
    [Abstract] [Full Text] [Related]

  • 19. Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization.
    Houltz B, Darpö B, Swedberg K, Blomström P, Crijns HJ, Jensen SM, Svernhage E, Edvardsson N.
    Europace; 2000 Jan 15; 2(1):20-31. PubMed ID: 11225593
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
    Verduyn SC, Vos MA, Leunissen HD, van Opstal JM, Wellens HJ.
    J Cardiovasc Pharmacol; 1999 Feb 15; 33(2):212-22. PubMed ID: 10028928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.